Skip to content

Parental Education on Passive Smoke Exposure and Respiratory Diseases in Infants

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00757224
Enrollment
150
Registered
2008-09-23
Start date
2008-10-31
Completion date
2009-10-31
Last updated
2008-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Smoke Pollution

Brief summary

Parental smoking is associated with increased frequency of respiratory diseases including hospitalizations in infants. Study hypothesis: Parental education regarding the association between parental smoking and respiratory diseases in the infant, and guidance on ways to decrease smoke exposure by the infant, provided shortly after the infant is born, will decrease infants' morbidity.

Detailed description

Mothers who are in Maternity ward following birth will fill a questionnaire regarding smoking habits. Parents will be divided into non-smokers and smokers. Half of the smoking mothers will receive guidance regarding the association between parents smoking and respiratory diseases in the infant. They will also get ideas on how to reduce smoke exposure by their infant. 3 months and 1 year later all parents will be contacted by phone and asked about their children's health.

Interventions

BEHAVIORALGuidance

Smoking parents will receive education on the association between parental smoking and respiratory morbidity in the infant. They will also be offered ways to reduce smoke exposure of their infants.

Sponsors

Assaf-Harofeh Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Days to 3 Days
Healthy volunteers
Yes

Inclusion criteria

* Infants born at Asaf Harofeh Medical Center * Infants born at \>35W gestational age

Exclusion criteria

* Infants requiring any supportive treatment (supplemental O2, fluids, glucose, antibiotics)

Design outcomes

Primary

MeasureTime frame
The number of episodes of cough/wheeze/asthma/bronchitis during the first 3 months and 1 year.3 months and 1 year

Secondary

MeasureTime frame
The number of ED visits and hospitalizations for respiratory diseases in the first 3 months and 1 year3 months and 1 year

Countries

Israel

Contacts

Primary ContactArnon Elizur, MD
elizura@gmail.com972-8-9779817

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026